MedTrace Logo

Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) Glaucoma Drainage Implant

NCT01563237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2021-06-24

Study results available
· View outcomes & findings →

Summary

To assess the safety and performance of the MIDI Arrow in patients suffering from glaucoma that is inadequately controlled on maximum tolerated medical therapy with intraocular pressure ≥ 18 mm Hg and ≤ 40 mm Hg

Conditions

  • Primary Open Angle Glaucoma

Interventions

DEVICE

MIDI Arrow

Implantation of MIDI Arrow

Sponsors & Collaborators

  • InnFocus Inc.

    lead INDUSTRY

Principal Investigators

  • Isabelle M Riss, MD · Clinique Mutualiste de Pessac, Pessac, France

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2016-12-31
Completion
2017-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01563237 on ClinicalTrials.gov